ImmunityBio, Inc. (IBRX)
7.24
+0.07
(+0.98%)
USD |
NASDAQ |
Jun 09, 16:00
7.24
0.00 (0.00%)
After-Hours: 19:33
ImmunityBio SG&A Expense (Quarterly) : 45.77M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Sana Biotechnology, Inc. | 11.46M |
| Erasca, Inc. | 10.65M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Denali Therapeutics, Inc. | 33.51M |
| Cogent Biosciences, Inc. | 28.24M |